PIK3CG and breast cancer: Another study tested several metabolic inhibitors including BEZ235, GDC0980 (dual PI3K/mTOR inhibitors), or LY294002 and GDC0942 (PI3K inhibitors) showing an inhibition of cell proliferation of breast cancer cells in high glucose media (54).